VectivBio Ownership 2024 | Who Owns VectivBio Now?
Institutional Ownership
1.16%
Insider Ownership
4.50%
Retail Ownership
94.35%
Institutional Holders
1.00
VectivBio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANAAN PARTNERS XI LLC | 0.10% | 0.23% | 37,051 | - | - | 315,304,000 | Mar 31, 2023 |
| CHI ADVISORS LLC | 0.01% | 11.87% | 5,255,484 | -237,409 | -4.32% | 44,724,170,000 | Mar 31, 2023 |
| ORBIMED ADVISORS LLC | 0.01% | 0.86% | 5,156,561 | -1,850,300 | -26.41% | 43,882,334,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.01% | 0.01% | 3,967,537 | -298 | -0.01% | 34,120,818,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.01% | 0.58% | 3,675,644 | 270,000 | 7.93% | 31,610,538,000 | Mar 31, 2023 |
| NOVO HOLDINGS A/S | 0.01% | 2.03% | 3,610,461 | 270,977 | 8.11% | 30,725,023,000 | Mar 31, 2023 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.01% | 5.16% | 3,113,600 | 780,300 | 33.44% | 26,496,736,000 | Mar 31, 2023 |
| BPIFRANCE SA | 0.01% | 0.61% | 2,806,217 | - | - | 23,880,907,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 0.01% | 1.42% | 2,536,617 | - | - | 21,587,000 | Mar 31, 2023 |
| VIVO CAPITAL, LLC | 0.01% | 1.38% | 2,333,300 | - | - | 19,856,383,000 | Mar 31, 2023 |
| VR ADVISER, LLC | 0.00% | 3.10% | 1,866,000 | - | - | 15,879,660,000 | Mar 31, 2023 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.00% | 0.21% | 1,768,198 | 51,542 | 3.00% | 15,206,503,000 | Mar 31, 2023 |
| MARSHALL WACE, LLP | 0.00% | 0.03% | 1,669,656 | 300,000 | 21.90% | 14,359,042,000 | Mar 31, 2023 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.00% | 0.84% | 1,352,199 | 18,799 | 1.41% | 11,628,911,000 | Mar 31, 2023 |
| BLACKSTONE INC. | 0.00% | 0.05% | 1,333,333 | - | - | 11,466,664,000 | Mar 31, 2023 |
| TEKLA CAPITAL MANAGEMENT LLC | 0.00% | 0.22% | 682,834 | -54,870 | -7.44% | 5,872,372,000 | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.00% | 0.01% | 409,100 | 409,100 | 100.00% | 3,481,441,000 | Mar 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.00% | 0.01% | 322,418 | -20,866 | -6.08% | 2,772,795,000 | Mar 31, 2023 |
| CAXTON CORP | 0.00% | 3.40% | 156,651 | 429 | 0.27% | 1,345,549,000 | Mar 31, 2023 |
| PFM HEALTH SCIENCES, LP | 0.00% | 0.05% | 131,922 | 106,381 | 416.51% | 1,122,656,000 | Mar 31, 2023 |
VectivBio's largest institutional shareholder is CANAAN PARTNERS XI LLC, holding 0.10% of the company's total share outstanding, currently valued at $315.30M. The top 10 institutional shareholders own together 0.18% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHI ADVISORS LLC | 0.01% | 11.87% | 5,255,484 | -237,409 | -4.32% | 44,724,170,000 | Mar 31, 2023 |
| TCG CROSSOVER MANAGEMENT, LLC | 0.01% | 5.16% | 3,113,600 | 780,300 | 33.44% | 26,496,736,000 | Mar 31, 2023 |
| CAXTON CORP | 0.00% | 3.40% | 156,651 | 429 | 0.27% | 1,345,549,000 | Mar 31, 2023 |
| VR ADVISER, LLC | 0.00% | 3.10% | 1,866,000 | - | - | 15,879,660,000 | Mar 31, 2023 |
| NOVO HOLDINGS A/S | 0.01% | 2.03% | 3,610,461 | 270,977 | 8.11% | 30,725,023,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 0.01% | 1.42% | 2,536,617 | - | - | 21,587,000 | Mar 31, 2023 |
| VIVO CAPITAL, LLC | 0.01% | 1.38% | 2,333,300 | - | - | 19,856,383,000 | Mar 31, 2023 |
| ORBIMED ADVISORS LLC | 0.01% | 0.86% | 5,156,561 | -1,850,300 | -26.41% | 43,882,334,000 | Mar 31, 2023 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.00% | 0.84% | 1,352,199 | 18,799 | 1.41% | 11,628,911,000 | Mar 31, 2023 |
| BPIFRANCE SA | 0.01% | 0.61% | 2,806,217 | - | - | 23,880,907,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.01% | 0.58% | 3,675,644 | 270,000 | 7.93% | 31,610,538,000 | Mar 31, 2023 |
| REGENCY CAPITAL MANAGEMENT INC.\DE | 0.00% | 0.39% | 38,000 | 38,000 | 100.00% | 323,380,000 | Mar 31, 2023 |
| CANAAN PARTNERS XI LLC | 0.10% | 0.23% | 37,051 | - | - | 315,304,000 | Mar 31, 2023 |
| TEKLA CAPITAL MANAGEMENT LLC | 0.00% | 0.22% | 682,834 | -54,870 | -7.44% | 5,872,372,000 | Mar 31, 2023 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.00% | 0.21% | 1,768,198 | 51,542 | 3.00% | 15,206,503,000 | Mar 31, 2023 |
| PFM HEALTH SCIENCES, LP | 0.00% | 0.05% | 131,922 | 106,381 | 416.51% | 1,122,656,000 | Mar 31, 2023 |
| BLACKSTONE INC. | 0.00% | 0.05% | 1,333,333 | - | - | 11,466,664,000 | Mar 31, 2023 |
| VALUES FIRST ADVISORS, INC. | - | 0.04% | 8,112 | 8,112 | 100.00% | 69,031,000 | Mar 31, 2023 |
| OCTAGON CAPITAL ADVISORS LP | 0.00% | 0.04% | 35,259 | 35,259 | 100.00% | 300,054,000 | Mar 31, 2023 |
| MARSHALL WACE, LLP | 0.00% | 0.03% | 1,669,656 | 300,000 | 21.90% | 14,359,042,000 | Mar 31, 2023 |
The largest VectivBio shareholder by % of total assets is CHI ADVISORS LLC. The company owns 5.26M shares of VectivBio (VECT), representing 11.87% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 0.01% | 5.16% | 3,113,600 | 780,300 | 33.44% | 26,496,736,000 | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.00% | 0.01% | 409,100 | 409,100 | 100.00% | 3,481,441,000 | Mar 31, 2023 |
| MARSHALL WACE, LLP | 0.00% | 0.03% | 1,669,656 | 300,000 | 21.90% | 14,359,042,000 | Mar 31, 2023 |
| NOVO HOLDINGS A/S | 0.01% | 2.03% | 3,610,461 | 270,977 | 8.11% | 30,725,023,000 | Mar 31, 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.01% | 0.58% | 3,675,644 | 270,000 | 7.93% | 31,610,538,000 | Mar 31, 2023 |
| PFM HEALTH SCIENCES, LP | 0.00% | 0.05% | 131,922 | 106,381 | 416.51% | 1,122,656,000 | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | 0.00% | 0.01% | 104,819 | 104,819 | 100.00% | 901,443,000 | Mar 31, 2023 |
| GILDER GAGNON HOWE & CO LLC | 0.00% | 0.01% | 56,137 | 56,137 | 100.00% | 477,726,000 | Mar 31, 2023 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.00% | 0.21% | 1,768,198 | 51,542 | 3.00% | 15,206,503,000 | Mar 31, 2023 |
| REGENCY CAPITAL MANAGEMENT INC.\DE | 0.00% | 0.39% | 38,000 | 38,000 | 100.00% | 323,380,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 39,741 | 35,353 | 805.67% | 338,196,000 | Mar 31, 2023 |
| OCTAGON CAPITAL ADVISORS LP | 0.00% | 0.04% | 35,259 | 35,259 | 100.00% | 300,054,000 | Mar 31, 2023 |
| GOLDMAN SACHS GROUP INC | 0.00% | - | 27,077 | 27,077 | 100.00% | 230,425,000 | Mar 31, 2023 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.00% | 0.84% | 1,352,199 | 18,799 | 1.41% | 11,628,911,000 | Mar 31, 2023 |
| VALUES FIRST ADVISORS, INC. | - | 0.04% | 8,112 | 8,112 | 100.00% | 69,031,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.00% | - | 24,647 | 1,593 | 6.91% | 211,964,000 | Mar 31, 2023 |
| CAXTON CORP | 0.00% | 3.40% | 156,651 | 429 | 0.27% | 1,345,549,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | 0.00% | 277 | 277 | 100.00% | 2,000 | Mar 31, 2023 |
| MORGAN STANLEY | - | - | 2,262 | - | - | 19,250,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | 4,190 | - | - | 35,657,000 | Mar 31, 2023 |
As of Mar 31 2023, VectivBio's largest institutional buyer is TCG CROSSOVER MANAGEMENT, LLC. The company purchased 780.30K stocks of VECT, valued at $26.50B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0.01% | 0.86% | 5,156,561 | -1,850,300 | -26.41% | 43,882,334,000 | Mar 31, 2023 |
| CHI ADVISORS LLC | 0.01% | 11.87% | 5,255,484 | -237,409 | -4.32% | 44,724,170,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | 0.00% | 56,120 | -197,757 | -77.89% | 477,582,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -165,333 | -100.00% | - | Mar 31, 2023 |
| TEKLA CAPITAL MANAGEMENT LLC | 0.00% | 0.22% | 682,834 | -54,870 | -7.44% | 5,872,372,000 | Mar 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.00% | 0.01% | 322,418 | -20,866 | -6.08% | 2,772,795,000 | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -19,233 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | 0.00% | 0.00% | 80,474 | -802 | -0.99% | 692,076,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.01% | 0.01% | 3,967,537 | -298 | -0.01% | 34,120,818,000 | Mar 31, 2023 |
| VR ADVISER, LLC | 0.00% | 3.10% | 1,866,000 | - | - | 15,879,660,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 0.01% | 1.42% | 2,536,617 | - | - | 21,587,000 | Mar 31, 2023 |
| VIVO CAPITAL, LLC | 0.01% | 1.38% | 2,333,300 | - | - | 19,856,383,000 | Mar 31, 2023 |
| BPIFRANCE SA | 0.01% | 0.61% | 2,806,217 | - | - | 23,880,907,000 | Mar 31, 2023 |
| CANAAN PARTNERS XI LLC | 0.10% | 0.23% | 37,051 | - | - | 315,304,000 | Mar 31, 2023 |
| BLACKSTONE INC. | 0.00% | 0.05% | 1,333,333 | - | - | 11,466,664,000 | Mar 31, 2023 |
| BARCLAYS PLC | - | - | 9,407 | - | - | 80,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | 4,190 | - | - | 35,657,000 | Mar 31, 2023 |
| MORGAN STANLEY | - | - | 2,262 | - | - | 19,250,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | 0.00% | 277 | 277 | 100.00% | 2,000 | Mar 31, 2023 |
| CAXTON CORP | 0.00% | 3.40% | 156,651 | 429 | 0.27% | 1,345,549,000 | Mar 31, 2023 |
As of Mar 31 2023, VectivBio's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -1.85M shares of VECT, valued at $43.88B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.00% | 0.01% | 409,100 | 409,100 | 100.00% | 3,481,441,000 | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | 0.00% | 0.01% | 104,819 | 104,819 | 100.00% | 901,443,000 | Mar 31, 2023 |
| GILDER GAGNON HOWE & CO LLC | 0.00% | 0.01% | 56,137 | 56,137 | 100.00% | 477,726,000 | Mar 31, 2023 |
| REGENCY CAPITAL MANAGEMENT INC.\DE | 0.00% | 0.39% | 38,000 | 38,000 | 100.00% | 323,380,000 | Mar 31, 2023 |
| OCTAGON CAPITAL ADVISORS LP | 0.00% | 0.04% | 35,259 | 35,259 | 100.00% | 300,054,000 | Mar 31, 2023 |
| GOLDMAN SACHS GROUP INC | 0.00% | - | 27,077 | 27,077 | 100.00% | 230,425,000 | Mar 31, 2023 |
| VALUES FIRST ADVISORS, INC. | - | 0.04% | 8,112 | 8,112 | 100.00% | 69,031,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | 0.00% | 277 | 277 | 100.00% | 2,000 | Mar 31, 2023 |
VectivBio's largest new institutional shareholder by number of shares is ADAGE CAPITAL PARTNERS GP, L.L.C., purchased 409.10K shares, valued at $3.48B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -165,333 | -100.00% | - | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -19,233 | -100.00% | - | Mar 31, 2023 |
VectivBio's largest sold out institutional shareholder by shares sold is NATIONAL BANK OF CANADA /FI/, sold -0.17M shares, valued at -, as of undefined.
VectivBio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Investment Managers Series Trust II | 0.01% | 131,874 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 41,549 | - | - | Mar 28, 2024 |
| NEXPOINT FUNDS I | 0.00% | 8,351 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 63,298 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 3,675,644 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 27,715 | - | - | Feb 29, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 69,979 | - | - | Feb 29, 2024 |
VectivBio's largest mutual fund holder by % of total assets is "Investment Managers Series Trust II", owning 131.87K shares, compromising 0.01% of its total assets.
VectivBio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | - |
| 31 Dec, 23 | 1 | -50.00% |
| 30 Sep, 23 | 2 | -96.23% |
| 30 Jun, 23 | 53 | 51.43% |
| 31 Mar, 23 | 35 | 25.00% |
| 31 Dec, 22 | 28 | 33.33% |
| 30 Sep, 22 | 21 | 5.00% |
| 30 Jun, 22 | 20 | 25.00% |
| 31 Mar, 22 | 16 | -20.00% |
| 31 Dec, 21 | 20 | -13.04% |
| 30 Sep, 21 | 23 | -4.17% |
| 30 Jun, 21 | 24 | - |
As of 31 Mar 24, 1 institutions are holding VectivBio's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 510,000 | - |
| 31 Dec, 23 | 510,000 | 1551.55% |
| 30 Sep, 23 | 30,880 | -99.90% |
| 30 Jun, 23 | 29,773,722 | -30.30% |
| 31 Mar, 23 | 42,714,192 | 0.02% |
| 31 Dec, 22 | 42,704,018 | 52.62% |
| 30 Sep, 22 | 27,980,400 | 0.41% |
| 30 Jun, 22 | 27,865,594 | 19.39% |
| 31 Mar, 22 | 23,339,232 | 0.28% |
| 31 Dec, 21 | 23,273,975 | -1.88% |
| 30 Sep, 21 | 23,721,076 | 1.87% |
| 30 Jun, 21 | 23,284,739 | - |
VectivBio (VECT) has 510.00K shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 1.16% | 86.52% |
| 31 Dec, 23 | 1.16% | 23593.57% |
| 30 Sep, 23 | 0.07% | 0.00% |
| 30 Jun, 23 | 67.47% | 0.72% |
| 31 Mar, 23 | 96.80% | 1.03% |
| 31 Dec, 22 | 96.78% | 2.41% |
| 30 Sep, 22 | 63.41% | 0.59% |
| 30 Jun, 22 | 103.37% | 1.38% |
| 31 Mar, 22 | 86.58% | 1.16% |
| 31 Dec, 21 | 86.34% | 1.12% |
| 30 Sep, 21 | 88.00% | 1.18% |
| 30 Jun, 21 | 86.38% | - |
As of 31 Mar 24, VectivBio is held by 1.16% institutional shareholders, representing a 86.52% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | -100.00% |
| 31 Dec, 23 | 1 | - |
| 30 Sep, 23 | 1 | -97.62% |
| 30 Jun, 23 | 42 | 121.05% |
| 31 Mar, 23 | 19 | 18.75% |
| 31 Dec, 22 | 16 | 128.57% |
| 30 Sep, 22 | 7 | -36.36% |
| 30 Jun, 22 | 11 | 120.00% |
| 31 Mar, 22 | 5 | -44.44% |
| 31 Dec, 21 | 9 | - |
| 30 Sep, 21 | 9 | -62.50% |
| 30 Jun, 21 | 24 | - |
- institutional shareholders have increased their position in VECT stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | - |
| 31 Dec, 23 | - | - |
| 30 Sep, 23 | - | -100.00% |
| 30 Jun, 23 | 5 | -28.57% |
| 31 Mar, 23 | 7 | 40.00% |
| 31 Dec, 22 | 5 | -16.67% |
| 30 Sep, 22 | 6 | 50.00% |
| 30 Jun, 22 | 4 | -33.33% |
| 31 Mar, 22 | 6 | - |
| 31 Dec, 21 | 6 | -14.29% |
| 30 Sep, 21 | 7 | - |
| 30 Jun, 21 | - | - |
- institutional shareholders have reduced their position in VECT stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 1 | - | 510,000 | - | 1.16% | 86.52% | - | -100.00% | - | - |
| 31 Dec, 23 | 1 | -50.00% | 510,000 | 1551.55% | 1.16% | 23593.57% | 1 | - | - | - |
| 30 Sep, 23 | 2 | -96.23% | 30,880 | -99.90% | 0.07% | 0.00% | 1 | -97.62% | - | -100.00% |
| 30 Jun, 23 | 53 | 51.43% | 29,773,722 | -30.30% | 67.47% | 0.72% | 42 | 121.05% | 5 | -28.57% |
| 31 Mar, 23 | 35 | 25.00% | 42,714,192 | 0.02% | 96.80% | 1.03% | 19 | 18.75% | 7 | 40.00% |
| 31 Dec, 22 | 28 | 33.33% | 42,704,018 | 52.62% | 96.78% | 2.41% | 16 | 128.57% | 5 | -16.67% |
| 30 Sep, 22 | 21 | 5.00% | 27,980,400 | 0.41% | 63.41% | 0.59% | 7 | -36.36% | 6 | 50.00% |
| 30 Jun, 22 | 20 | 25.00% | 27,865,594 | 19.39% | 103.37% | 1.38% | 11 | 120.00% | 4 | -33.33% |
| 31 Mar, 22 | 16 | -20.00% | 23,339,232 | 0.28% | 86.58% | 1.16% | 5 | -44.44% | 6 | - |
| 31 Dec, 21 | 20 | -13.04% | 23,273,975 | -1.88% | 86.34% | 1.12% | 9 | - | 6 | -14.29% |
| 30 Sep, 21 | 23 | -4.17% | 23,721,076 | 1.87% | 88.00% | 1.18% | 9 | -62.50% | 7 | - |
| 30 Jun, 21 | 24 | - | 23,284,739 | - | 86.38% | - | 24 | - | - | - |
VectivBio Peer Ownership
VECT Ownership FAQ
Who Owns VectivBio?
VectivBio is owned by institutional shareholders (1.16%), insiders (4.50%), and public (94.35%). The largest institutional shareholder of VectivBio is CANAAN PARTNERS XI LLC (0.10% of total shares) and the top mutual fund owner is Investment Managers Series Trust II (0.01% of total shares).
Who are the major institutional shareholders of VectivBio?
VectivBio's major institutional shareholders are CANAAN PARTNERS XI LLC, CHI ADVISORS LLC, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, and EVENTIDE ASSET MANAGEMENT, LLC. The top five shareholders own together 0.15% of the company's share outstanding.
How many VectivBio shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of VectivBio.
What percentage of VectivBio is owned by CANAAN PARTNERS XI LLC?
CANAAN PARTNERS XI LLC owns 37.05K shares of VectivBio, representing 0.10% of the company's total shares outstanding, valued at $315.3M (as of Mar 2023).
What percentage of VectivBio is owned by CHI ADVISORS LLC?
As of Mar 2023, CHI ADVISORS LLC holds 5.26M shares of VectivBio (VECT), compromising 0.01% of the company, valued at $44.72B.
What percentage of VectivBio is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC is the third largest holder of VectivBio. The company owns 5.16M of the company's shares outstanding (worth $43.88B).